Dieser Wirkstoff kann morgens und abends angewendet werden und birgt kein Risiko einer Photosensibilisierung
Am J Clin Dermatol 22:891900
Here, in this randomized, double-blind, placebo-controlled trial, participants ( n = 98) were randomly assigned to 48 weeks of once-weekly subcutaneous retatrutide (1, 4, 8 or 12 mg dose) or placebo
3,5 Additional preclinical and clinical research suggests that konjac glucomannan may support gastrointestinal regularity, improve constipation symptoms, and contribute to immune regulation through interactions with intestinal microbiota and inflammatory signaling pathways
Now, it's being used by top weight loss doctors in Arlington, TX, to help people safely and effectively reduce appetite and lose weight